Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2461 to 2475 of 9000 results

  1. Tislelizumab for untreated unresectable hepatocellular carcinoma [TSID10683]

    Awaiting development Reference number: GID-TA11053 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]

    Awaiting development Reference number: GID-TA10776 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. Sacituzumab tirumotecan for treating advanced or metastatic gastric, gastro-oesophageal junction or oesophageal adenocarcinoma after 2 or more treatment lines [ID6723]

    Awaiting development Reference number: GID-TA11932 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. NeuroSAFE for Intra-operative frozen section evaluation of neurovascular bundle adjacent prostate capsule during radical prostatectomy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Orbital atherectomy for calcified coronary artery disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. MRI guided transurethral high intensity ultrasound ablation of the prostate

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. EchoLaser percutaneous laser ablation treatment for patients with neck lesions

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  10. Pancreas SABR

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Stockholm3 blood test for prostate cancer, (MT734),

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  12. CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease (MT434

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  13. Spartan RX point-of-care CYP2C19 test

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  14. Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Sonesitatug vedotin for previously treated metastatic claudin 18.2-positive gastric or gastro-oesophageal junction adenocarcinomar [ID6669]

    Awaiting development Reference number: GID-TA11879 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development